P&S Journal: Winter 1995, Vol.15, No.1
The Renaissance Reshaping Cancer at CPMC
Changes At CPCC
To facilitate "translational research," CPCC has undergone many changes. A new position was created for a deputy director, Dr. Riccardo Dalla-Favera, the Percy and Joanne Uris Professor of Pathology. His goal is "to help bridge the gap between basic and clinical science."
He plans to bring physicians and researchers together to help orient basic research toward clinical questions, a philosophy present in his own laboratory. A physician-scientist, Dr. Dalla-Favera identifies and studies oncogenes in lymphomas for knowledge ultimately used in patient diagnosis and treatment.
"In the past, basic and clinical scientists didn't interact very much," says Dr. Dalla-Favera. "Ph.D.s and M.D.s have different backgrounds, speak a different language. But cross-fertilization is good, and we are encouraging it."
An example of that cross fertilization is the creation of the oncology division in the pathology department. Dr. Dalla-Favera oversees the six-investigator division, which he says is the largest concentration of basic scientists bridging clinical cancer issues in any CPMC department (see table on page 17).